Zimmer Biomet Holdings, Inc. provided earnings guidance for the full year 2024. The company expects 2024 reported revenue change to be 4.5% - 5.5%.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
115.2 USD | +0.62% | -1.08% | -5.38% |
May. 31 | Zimmer Biomet's Limited Exposure to High-Growth Markets Spurs Revenue Concerns, UBS Says | MT |
May. 31 | Barclays Adjusts Price Target on Zimmer Biomet to $125 From $130 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.38% | 23.69B | |
-7.16% | 178B | |
-1.23% | 107B | |
-4.86% | 67.04B | |
-4.28% | 47.23B | |
+10.32% | 44.62B | |
+8.14% | 42.5B | |
+15.76% | 29.99B | |
+15.53% | 25.22B | |
-5.88% | 24.14B |
- Stock Market
- Equities
- ZBH Stock
- News Zimmer Biomet Holdings, Inc.
- Zimmer Biomet Holdings, Inc. Provides Earnings Guidance for the Full Year 2024